---
title: ADAL02
subtitle: Listing of Anti-Drug Antibody Data for Treatment Emergent ADA Positive Patients
---

------------------------------------------------------------------------

{{< include ../../test-utils/envir_hook.qmd >}}

::: panel-tabset
## Data Setup

```{r setup, message=FALSE}
#| code-fold: show

library(dplyr)
library(rlistings)
library(scda)

adab <- synthetic_cdisc_dataset("latest", "adab") %>%
  filter(NFRLT %% 1 == 0 & NFRLT > 0)

trt <- "A: Drug X"
drug_a <- "A: Drug X Antibody"
drugcd <- unique(adab$PARAMCD[adab$PARAM == "Antibody titer units"])[1]
min_titer <- 1.10

adab_x <- adab %>%
  filter(
    ARM == trt,
    PARCAT1 == drug_a,
    ADPBLPFL == "Y"
  ) %>%
  select(-PARAMCD, -AVALC, -AVALU, -ARRLT, -NRRLT) %>%
  unique() %>%
  tidyr::pivot_wider(
    names_from = PARAM,
    values_from = AVAL
  ) %>%
  filter(if_any(matches("Treatment Emergent - Positive"), ~ .x == 1)) %>%
  # filter(`Treatment Emergent - Positive` == 1) %>%
  mutate(
    VISN = factor(paste0(
      VISIT, "\n(Day ",
      ifelse(
        NFRLT %% 1 == 0,
        NFRLT,
        as.character(format(round(NFRLT, 2), nsmall = 2))
      ),
      ")"
    )),
    PTES = ifelse(
      ifelse("Treatment induced ADA" %in% names(.), `Treatment induced ADA` == 1, FALSE),
      ifelse(
        "Transient ADA" %in% names(.) & `Transient ADA` == 1,
        "Induced (Transient)",
        "Induced (Persistent)"
      ),
      "Enhanced"
    )
  ) %>%
  mutate(
    AVAL = paste0(
      ifelse(
        ifelse("ADA interpreted per sample result" %in% names(.), `ADA interpreted per sample result` == 0, FALSE),
        "NEGATIVE",
        ifelse(
          ifelse("Antibody titer units" %in% names(.), !is.na(`Antibody titer units`), FALSE),
          ifelse(
            `Antibody titer units` < min_titer,
            paste0("<", format(min_titer, nsmall = 2)),
            as.character(format(round(`Antibody titer units`, 2), nsmall = 2))
          ),
          "---"
        )
      ),
      ifelse(
        ifelse("NAB interpreted per sample result" %in% names(.), `NAB interpreted per sample result` == 1, FALSE),
        "*",
        ""
      )
    )
  )

out <- adab_x %>%
  select(USUBJID, VISN, AVAL, PTES) %>%
  tidyr::pivot_wider(
    names_from = VISN,
    values_from = AVAL
  ) %>%
  select(USUBJID, unique(adab_x$VISN[order(adab_x$NFRLT)]), PTES)

var_labels(out) <- names(out)

out <- out %>%
  var_relabel(
    USUBJID = "Subject ID",
    PTES = "Patient Treatment\nEmergent ADA Status"
  )
```

## Standard Listing

```{r lsting, test = list(lsting = "lsting")}
lsting <- as_listing(
  out,
  key_cols = "USUBJID",
  disp_cols = names(out),
  main_title = paste0(
    "Listing of Anti-", drugcd, " Antibody Data for Treatment Emergent ADA Positive Patients, PK Population",
    "\nProtocol: ", unique(adab$PARCAT1)[1]
  ),
  subtitles = paste("\nTreatment Group:", trt),
  # nolint start: line_length.
  main_footer = "Minimum reportable titer = 1.10 (example only)
--- = No sample evaluated
ADA = Anti-Drug Antibodies (is also referred to as ATA, or Anti-Therapeutic Antibodies)
Number of patients positive for Treatment Emergent ADA = the number of post-baseline evaluable patients determined to have treatment-induced ADA or treatment-enhanced ADA during the study period.
Treatment-induced ADA = a patient with negative or missing baseline ADA result(s) and at least one positive post-baseline ADA result.
Treatment-enhanced ADA = a patient with positive ADA result at baseline who has one or more post-baseline titer results that are at least 0.60 t.u. greater than the baseline titer result.
Transient ADA = ADA positive result detected (a) at only one post-baseline sampling timepoint (excluding last timepoint) OR (b) at 2 or more timepoints during treatment where the first and last ADA positive samples  are separated by a period of < 16 weeks, irrespective of any negative samples in between.
Persistent ADA =  ADA positive result detected (a) at the last post-baseline sampling timepoint, OR (b) at 2 or more time points during treatment where the first and last ADA positive samples are separated by a period â‰¥ 16 weeks, irrespective of any negative samples in between.
Asterisk denotes sample that tested positive for Neutralizing Antibodies."
  # nolint end: line_length.
)

head(lsting, 20)
```

{{< include ../../test-utils/save_results.qmd >}}

{{< include ../../repro.qmd >}}
:::
